U.S. Markets closed
  • S&P Futures

    4,534.50
    +10.25 (+0.23%)
     
  • Dow Futures

    34,977.00
    +67.00 (+0.19%)
     
  • Nasdaq Futures

    15,084.75
    +51.25 (+0.34%)
     
  • Russell 2000 Futures

    2,062.00
    +2.80 (+0.14%)
     
  • Crude Oil

    86.55
    -0.41 (-0.47%)
     
  • Gold

    1,841.30
    -1.90 (-0.10%)
     
  • Silver

    24.25
    +0.01 (+0.06%)
     
  • EUR/USD

    1.1357
    +0.0010 (+0.0909%)
     
  • 10-Yr Bond

    1.8270
    -0.0380 (-2.04%)
     
  • Vix

    23.85
    +1.06 (+4.65%)
     
  • GBP/USD

    1.3627
    +0.0015 (+0.1131%)
     
  • USD/JPY

    114.3370
    -0.0160 (-0.0140%)
     
  • BTC-USD

    41,980.88
    -285.22 (-0.67%)
     
  • CMC Crypto 200

    995.04
    +0.29 (+0.03%)
     
  • FTSE 100

    7,589.66
    +26.11 (+0.35%)
     
  • Nikkei 225

    27,594.29
    +127.06 (+0.46%)
     

Better Buy: Johnson & Johnson or All 30 Dow Jones Stocks?

·4 min read
Better Buy: Johnson & Johnson or All 30 Dow Jones Stocks?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of healthcare giant Johnson & Johnson (NYSE: JNJ) have lagged the broad market since last year's low, but they've been outright poor performers since peaking in August of this year. Ergo, investors with some idle money ready to be put to work could easily conclude that something more broad-based like the SPDR Dow Jones Industrial Average ETF Trust (NYSEMKT: DIA) is a better bet than the individual component of the Dow Jones Industrial Average (DJINDICES: ^DJI) itself is right now. After all, the Dow remains within reach of record highs hit earlier this month, and is seemingly still going strong.